Champions Oncology Inc
F:2I3
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.84
11
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
2I3 Price Targets Summary
Champions Oncology Inc
According to Wall Street analysts, the average 1-year price target for
2I3
is 10.43 EUR
with a low forecast of 10.33 EUR and a high forecast of 10.74 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 2I3's stock price target?
Price Target
10.43
EUR
According to Wall Street analysts, the average 1-year price target for
2I3
is 10.43 EUR
with a low forecast of 10.33 EUR and a high forecast of 10.74 EUR.
What is Champions Oncology Inc's Revenue forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Champions Oncology Inc's revenue is
17%.
The projected
CAGR
for the next 3 years is
19%.
What is Champions Oncology Inc's Operating Income forecast?
Projected CAGR
26%
The
compound annual growth rate
of Champions Oncology Inc's operating income for the next 3 years is
26%.
What is Champions Oncology Inc's Net Income forecast?
Projected CAGR
-45%
The
compound annual growth rate
of Champions Oncology Inc's net income for the next 2 years is
-45%.
